CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

20 hedge funds and large institutions have $8.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$385K
2 +$364K
3 +$348K
4
BL
BCWM LLC
Kansas
+$140K
5
Citigroup
Citigroup
New York
+$82.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.61M
2
$771K
3
$539K
4
$462K
5
$457K
6
$409K
7
$350K
8
$348K
9
$245K
10
$242K
11
$194K
12
$109K
13
$43K
14
$31K
15
$27K
16
$21K
17
$21K
18
$15K
19
$3K
20
$2K
21
22
23
24